3/19/2026
DAISY Study Recruiting Now. Travel Compensation Included.
Does living with celiac disease impact your daily life? We need your help to advance celiac disease research and test an investigational medication.
Continue ReadingFeatured News
Tag: celiac drug
2/3/2026
Now enrolling patients in the FB102-301 study investigating a potential new celiac drug
Is celiac disease holding you back? If so, consider joining the FB102-301 study for people who have celiac disease who are currently on a gluten-free diet. The phase 2 FB102-301 study is researching a potential new…
Continue Reading10/24/2019
Cour Pharmaceuticals Announces Deal with Takeda for Celiac Treatment
Cour Pharmaceuticals has announced a $420 million licensing deal with Takeda Pharmaceuticals following a favorable outcome of their phase 2 trial for celiac disease. The company released data from a…
Continue Reading10/23/2019
Why You Should Be Tested Before Going Gluten-Free
Many people who suspect they have celiac disease choose to start a gluten-free diet right away, without a formal diagnosis. Here's why you shouldn't.
Continue ReadingRecent Posts
- DAISY Study Recruiting Now. Travel Compensation Included.
- Celiac Disease Foundation Launches Venture Fund to Transform the Future of Celiac Disease
- How Two Massachusetts Bills Could Pave the Way for Progress Towards Improved Celiac Disease Screening and School Meal Access
- Celiac Disease Advocates Take to Capitol Hill for our 2026 Advocacy Summit
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Impact Fund
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Recipes
- Research
- Research News
- Trending Topics
Marilyn's Message
3/18/2025
Read moreA Bold New Look for the Celiac Disease Foundation
Dear Celiac Disease Foundation Community, For more than three decades, the Celiac Disease Foundation has been dedicated to improving the lives of those affected by celiac disease through research, advocacy, and education. What began as a grassroots effort has grown into a global organization, leading the charge in accelerating diagnosis,...